<DOC>
	<DOCNO>NCT00931827</DOCNO>
	<brief_summary>The study examines use Mirena Implanon long-term contraception woman . The duration therapy use key focus study . Also , reason discontinuation safety profile examine . In addition , patient ask fill short questionnaire menstrual bleeding therapy .</brief_summary>
	<brief_title>Acceptability Long-term Progestin-only Contraception Europe</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Women age 2035 good general health request contraception Women use shortacting hormonal contraception ( combine progestogenonly pill , vaginal ring contraceptive patch ) least 3 cycle immediately enter study opt change either Mirena Implanon contraception Women give write informed consent participate study ( applicable ) The contraindication warning respective Summary Product Characteristics ( Mirena Implanon ) must follow . The decision start Mirena Implanon make clearly decision include patient study Patients breastfeed time inclusion study also exclude since breastfeed affect bleed pattern</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Contraception</keyword>
</DOC>